Abstract：
:Platelet and coagulation factor-dependent thrombus formation is critical to limit posttraumatic blood loss at sites of vascular injury. However, under pathological conditions like rupture of an atherosclerotic plaque, it may also lead to vessel occlusion causing myocardial infarction or stroke. Therefore, antithrombotic treatment is the prime therapeutic option in the prophylaxis and treatment of ischaemic cardio- and cerebrovascular diseases. The use of existing antithrombotic agents is, however, limited by their inherent effect on primary haemostasis. In recent years, major advances have been made in understanding the mechanisms of thrombus formation in haemostasis and thrombosis and some studies raised the interesting possibility that occlusive thrombus formation and haemostasis may involve partially different mechanisms. This review briefly summarizes these developments and highlights newly identified mechanisms involved in platelet adhesion and activation, intracellular calcium signaling, integrin activation and initiation of coagulation. The suitability of these pathways as novel targets for antithrombotic therapy is discussed.
journal_name
Hamostaseologiejournal_title
Hamostaseologieauthors
Hagedorn I,Vögtle T,Nieswandt Bsubject
Has Abstractpub_date
2010-08-01 00:00:00pages
127-35issue
3eissn
0720-9355issn
2567-5761pii
10030127journal_volume
30pub_type
杂志文章,评审相关文献
Hamostaseologie文献大全abstract：UNLABELLED:Antibodies against annexin-V, a potent anticoagulant abundant in placental tissues, were recently controversially reported to be associated with recurrent miscarriages or failures of in-vitro-fertilization (IVF) attempts. PATIENTS, MATERIAL, METHODS:We screened 56 women (34.7 +/- 4.3 years of age: mean +/- ...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2005-11-01 00:00:00
abstract：:Vitamin K-antagonists and heparin belong to the established indirect acting anticoagulants. For many years these drugs were the only possibility for prophylaxis and treatment of venous and arterial thrombosis. The challenges for the routine laboratory related to the treatment with vitamin K-antagonists and heparin can...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：
更新日期：2009-08-01 00:00:00
abstract：:This article reviews the current understanding of the pathophysiology of acute coronary syndrome and how these concepts have altered our clinical approach to the acute phase of coronary heart disease. Thrombosis due to erosion or, in most cases, rupture of a vulnerable atherosclerotic plaque underlies most acute coron...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：
更新日期：2006-05-01 00:00:00
abstract：:The structure-activity relationship of dipetalogastin II, the strongest thrombin inhibitor isolated and cloned from the bug Dipetalogaster maximus, was examined by introducing gradual changes into the molecule by means of molecular biological methods. The effect upon its inhibition equilibrium constant was determined ...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：10.1267/hämo05030267
更新日期：2005-08-01 00:00:00
abstract：:Unexplained intraoperative coagulopathies continue to be a diagnostic and therapeutic dilemma. The pathophysiology behind unexplained intraoperative coagulopathies is of great variety and complexity (preexisting coagulopathies, dilutional coagulopathy, interactions of medications etc.). We have shown in prospective st...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2006-08-01 00:00:00
abstract：:Vitamin K 2,3-epoxide reductase complex, subunit 1 (VKORC1) is an enzyme essential for the vitamin K cycle. VKORC1 catalyses the reduction of vitamin K 2,3-epoxide to the quinone form of vitamin K and further to vitamin K hydroquinone. The generated vitamin K hydroquinone serves as substrate for the enzyme γ-glutamyl-...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：
更新日期：2016-11-08 00:00:00
abstract：UNLABELLED:The retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. RESULTS:During the ob...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2012-01-01 00:00:00
abstract：UNLABELLED:The retrospective cohort study surveys the influence of age, co-morbidity and laboratory values on FVIII-activity (FVIII:C) in patients with haemophilia A with (mild n = 48, moderate n = 10, severe n = 7 and carriers n = 23). Median observation was 19 years for patients with haemophilia A and 9,5 years for c...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2011-11-01 00:00:00
abstract：INTRODUCTION: Platelet dysfunction is not uncommon in patients with end-stage renal disease (ESRD). Type of renal replacement therapy may have an effect on platelet functions, which has not been well investigated. We evaluated in vitro closure time (CT) differences between peritoneal dialysis (PD) and hemodialysis (HD)...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：10.1055/a-1171-0499
更新日期：2020-12-01 00:00:00
abstract：:Patients with diabetes are at increased risk of cardiovascular morbidity and mortality. While arteriosclerotic lesions have long been recognized as the underlying cause more recent studies suggest that alterations of the blood are also critically involved. Following plaque rupture, adherence of platelets is followed b...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：10.5482/HAMO-14-09-0039
更新日期：2015-01-01 00:00:00
abstract：:Characteristic features of disseminated intravascular coagulation (DIC) are the opposing risks of bleeding (due to consumptive coagulopathy and hyperfibrinolysis) and organ failure (due to widespread microvascular thromboses). The purpose of anticoagulation in DIC is to attenuate excessive thrombin generation and fibr...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：10.1055/s-0038-1675386
更新日期：2019-08-01 00:00:00
abstract：UNLABELLED:The doses of these drugs are barely tested and the potential clinical thromboembolic risk must be taken into account. Despite the widespread use of NOAC (non vitamin-K dependent oral anticoagulants) and recommendations of regulatory agencies and first consensus meeting on handling the bleeding situation unde...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2015-01-01 00:00:00
abstract：:Atherosclerosis and its sequelae have a major impact on morbidity and mortality. The rupture of an inflamed atherosclerotic plaque is a crucial event, since it can result in acute thrombotic closure of an arterial vessel, resulting e. g. in myocardial infarction or stroke. Not only detection of early plaque rupture wi...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：10.5482/HAMO-14-11-0061
更新日期：2015-01-01 00:00:00
abstract：:Obesity is a major cause for a spectrum of metabolic syndrome-related diseases that include insulin resistance, type 2 diabetes, and steatosis of the liver. Inflammation elicited by macrophages and other immune cells contributes to the metabolic abnormalities in obesity. In addition, coagulation activation following t...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：10.5482/HAMO-14-11-0068
更新日期：2015-01-01 00:00:00
abstract：:The occurrence of cerebral or retinal ischemic symptoms ipsilateral to high-grade internal carotid artery (ICA) stenosis indicates a status of instability with a substantial risk for future major stroke. Additionally, the detection of microembolic signals downstream of ICA stenosis is predictive for future cerebral is...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：
更新日期：2003-05-01 00:00:00
abstract：:Activated by calcium and thrombin, factor XIII (FXIIIa) cross-links fibrin, thus increasing the stability of the fibrin clot. Furthermore, the hemostatic and reparative function of factor XIIIa is mediated by cross-linking other proteins like alpha(2)-plasmin-inhibitor, fibronectin, and collagen. The FXIII Val34Leu po...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：
更新日期：2002-02-01 00:00:00
abstract：:Recombinant activated factor VII (rFVIIa) is a pro-haemostatic agent that can be used for patients with haemophilia and inhibiting antibodies towards a coagulation factor. Recombinant factor VIIa is, however, increasingly used for several other indications, including patients who experience serious and life-threatenin...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2009-01-01 00:00:00
abstract：:Recombinant interleukin-2 (rIL-2) is indicated for metastatic renal cell carcinoma and melanoma. Over recent years low-dose rIL-2 has been studied for the treatment of autoimmune diseases and acute coronary syndrome because of its ability to expand and activate T regulatory (Treg) cells. However, several medical condi...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：10.1055/a-1120-4064
更新日期：2020-12-01 00:00:00
abstract：:The translation of fundamental science-based constructs to the preemptive identification and optimal management of individuals with or those at risk for thrombotic disorders of the cardiovascular system has taken a step closer to being realized with the development of molecular technologies that include nucleic acid a...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2007-12-01 00:00:00
abstract：:Platelets play a crucial role in haemostasis and several pathophysiological processes. Collagen is a main initiator for platelet activation and aggregation. Given that Wnt signalling negatively regulates platelet function, and IWR-1 (a small molecule inhibitor for Wnt signalling) has the potential of inhibiting collag...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：10.1055/s-0038-1676822
更新日期：2019-11-01 00:00:00
abstract：:The antiphospholipid syndrome is defined as the occurrence of one or more episodes of vascular thrombosis and/or miscarriage together with antiphospholipid antibodies. Some of these antibodies can be detected via coagulation assays by prolonging phospholipids-dependent assays. These unspecific inhibitors are termed lu...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：10.1267/hämo05010050
更新日期：2005-02-01 00:00:00
abstract：:For the last decades, anticoagulation for stroke prevention in atrial fibrillation (AF) as well as for the prophylaxis and long-term treatment of venous thromboembolism has been entirely based on vitamin K antagonists (VKA). Although very effective under optimal conditions, long-term treatment with these drugs is flaw...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：10.5482/ha-12050008
更新日期：2012-01-01 00:00:00
abstract：:Hermansky-Pudlak syndrome (HPS) is a rare, autosomal recessive disorder affecting lysosome-related organelles (LRO), including dense platelet granules. HPS causes oculocutaneous hypopigmentation, bleeding diathesis and granulomatous colitis or pulmonary fibrosis. To date, there is no curative treatment and the clinica...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：10.5482/HAMO-14-06-0024
更新日期：2014-01-01 00:00:00
abstract：:Venous thromboembolism is a chronic and potential fatal disease. Determination of recurrence risk is time-consuming and costly, and sometimes not feasible: many patients carry more than one risk factor, the relevance of some factors with regard to risk of recurrence is unknown, and existence of thus far unknown risk f...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2008-02-01 00:00:00
abstract：:Platelet number or function disorders cause a range of bleeding symptoms from mild to severe. Patients with platelet dysfunction but normal platelet number are the most prevalent and typically have mild bleeding symptoms. The study of this group of patients is particularly difficult because of the lack of a gold-stand...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：
更新日期：2010-01-01 00:00:00
abstract：:Several challenges arise from the wide application of molecular genetic analyses, among them the need to introduce rules to evaluate molecular genetic test systems as well as test laboratories. This article specifically addresses laboratories performing molecular genetic tests for diagnosis, prevention and therapy of ...
journal_title：Hamostaseologie
pub_type： 杂志文章
doi：
更新日期：2010-05-01 00:00:00
abstract：:Direct oral anticoagulants (DOACs) are increasingly prescribed substances in patients with indication for effective anticoagulation. Patients with chronic kidney disease (CKD) have a high burden of cardiovascular risk and are more likely to develop atrial fibrillation (AF) than patients without CKD. Patients with mild...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：10.5482/HAMO-17-01-0003
更新日期：2017-01-01 00:00:00
abstract：:Patients suffering from haemophilia encounter various phases in life, in which individual needs, life situations, and self- and disease perception change rapidly. One of these phases spans from the beginning of puberty until early adulthood, in which individuals gain self-responsibility and reach independence and auto...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：10.1055/s-0039-3402804
更新日期：2020-02-01 00:00:00
abstract：:Coronary heart disease and stroke, the deadliest forms of cardiovascular disease (CVD), are mainly caused by atherosclerosis, a chronic inflammatory disease of the artery wall driven by maladaptive immune responses in the vessel wall. Various risk factors for CVD influence this pathogenic process, including diabetes m...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：10.5482/HAMO-14-10-0052
更新日期：2015-01-01 00:00:00
abstract：:This article reviews the roles of blood platelets in haemostasis as well as in the pathogenesis of thromboembolic diseases. Besides the basic processes in primary haemostasis, platelet adhesion, platelet secretion, platelet aggregation, clot retraction, the new model of thrombin formation on the platelet surface is pr...
journal_title：Hamostaseologie
pub_type： 杂志文章,评审
doi：
更新日期：2008-12-01 00:00:00
